免疫療法IKC | 美體產業公開資訊

長春藤生命科學在十餘年裡投入龐大的心力及資金在癌症的治療與預防上。從人體臨床數據得知，在免疫細胞療法中，大量繁殖自體免疫殺手細胞中的四種細胞： ...

 Immune Cell Therapy IKC®

Ivy Life Sciences has heavily invested in the field of cell therapy in the treatment and prevention of cancer for nearly 20 years. After years of research and clinical trials, our product Immune Killer Cells Therapy (IKC therapy) is simple in principle. We extract the immune cells from the patients blood, expand it and activate it over two weeks. The end product IKC®, contains four types of cells that can destroy cancer cells: Cytotoxic T cells, natural killer T cells, natural killer cells and γδ T cells and is injected by into the patient.

IKC®therapy has obtained international patents from the United States, Taiwan and China.